EN DE
STOCK COMPARISON

India Glycols vs Nigbas Nigde Beton Sanayi ve Ticaret AS: Fair Value & Quality

Both stocks run through our valuation models. Here is how India Glycols (INDIAGLYCO) and Nigbas Nigde Beton Sanayi ve Ticaret AS (NIBAS) compare, as of Aug 17, 2026.

As of Aug 17, 2026, Fair Value Calculator sees Nigbas Nigde Beton Sanayi ve Ticaret AS as the less overvalued of the two: India Glycols trades at ₹1,061 versus a fair value of ₹542 (-49%), while Nigbas Nigde Beton Sanayi ve Ticaret AS trades at TRY 3.49 versus TRY 2.87 (-18%).
India Glycols
INDIAGLYCO.NSE · INR · Materials
-49%
upside to fair value
overvalued
Price₹1,061
Fair Value₹542
Quality32/100
Nigbas Nigde Beton Sanayi ve Ticaret AS
NIBAS.IS · TRY · Industrials
-18%
upside to fair value
overvalued
PriceTRY 3.49
Fair ValueTRY 2.87
Quality26/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

India GlycolsNigbas Nigde Beton Sanayi ve Ticaret AS
Valuation
23.1×P/E (TTM)
1.71×P/S (TTM)0.22×
2.46×P/B0.06×
12.4×EV/EBITDA1.3×
1.0%Dividend yield0.0%
Profitability
7%Net margin0%
13%Operating margin-12%
11%Return on equity-73%
5%Return on assets0%
Growth
13%Revenue growth (YoY)72%
16.9%Avg. growth/yr (3Y)18.8%
12.9%Avg. growth/yr (5Y)31.5%
Balance & size
0.31×Debt / equity
$757MMarket cap$25M
expensiveGrowth qualityexpensive

Nigbas Nigde Beton Sanayi ve Ticaret AS leads: 5 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

India Glycolsof which business quality 35 · market factors 68 Nigbas Nigde Beton Sanayi ve Ticaret ASof which business quality 30 · market factors 22
ProfitabilityMargins and returns on capital today
37
4
Quality GrowthAre margins and returns improving?
50
76
CashflowEarnings quality: real cash, not paper profit
40
0
Fin. StrengthBalance sheet, leverage, solvency risk
46
63
InvestmentDisciplined investing over empire-building
24
3
Low VolatilityCalm price path (market factor)
76
50
MomentumPrice trend over the last 3–12 months (market factor)
64
16
52W MomentumDistance to the 52-week high (market factor)
68
1
Net IssuanceBuybacks instead of dilution
0
40

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

India Glycols

Earnings-Based₹473
Dividend Discount₹198
Multiples₹778
Asset-Based₹293
Economic Profit₹534
Growth Earnings₹638

15 of 16 models see the stock below the current price.

Nigbas Nigde Beton Sanayi ve Ticaret AS

Earnings-BasedTRY 2.09
Dividend DiscountTRY 0.52
MultiplesTRY 2.87
Asset-BasedTRY 22.44
Economic ProfitTRY 2.09

6 of 8 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

India Glycols
Bear ₹379Fair Value ₹542Bull ₹705
₹1,061 = current price (white tick)
Nigbas Nigde Beton Sanayi ve Ticaret AS
Bear TRY 1.91Fair Value TRY 2.87Bull TRY 3.82
TRY 3.49 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

India Glycols · Materials

Quality score32 · bottom 25%
Fair value upside-49% · below median

Nigbas Nigde Beton Sanayi ve Ticaret AS · Industrials

Quality score26 · bottom 25%
Fair value upside-18% · above median

Bottom line

As of Aug 17, 2026, Fair Value Calculator sees Nigbas Nigde Beton Sanayi ve Ticaret AS as the less overvalued of the two: India Glycols trades at ₹1,061 versus a fair value of ₹542 (-49%), while Nigbas Nigde Beton Sanayi ve Ticaret AS trades at TRY 3.49 versus TRY 2.87 (-18%).

India Glycols has the higher quality score (32/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.